Skip to content

Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound

Safety, Parameterization, and Mechanism of Transcranial Focused Ultrasound (fUS) Over the Motor Cortex

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05792020
Enrollment
25
Registered
2023-03-30
Start date
2026-07-01
Completion date
2028-12-31
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Transcranial Focused Ultrasound

Brief summary

Through the BrainBox Initiative, investigators propose to study the effects of motor tFUS on Motor Evoked Potentials (MEPs) and GABA and Glutamate Concentrations in the Brain.

Detailed description

tFUS is an emerging neuromodulatory tool that uses pulses of low-intensity acoustic waves to stimulate deep brain structures such as the thalamus. tFUS has recently been used to probe deep brain structures in unresponsive wakefulness, pain, anxiety, and other neuropsychiatric conditions. However, tFUS is restricted mainly by use in the MR scanner environment, thus limiting session numbers by scan cost and participant comfort. Furthermore, with few human studies to date, the parameter space and mechanisms of action warrant further elucidation. Using novel focused ultrasound methods, investigators can stimulate at a minimum penetration distance of 20mm, uniquely enabling the study of the neuromodulatory effects of tFUS on cortical tissue. Specifically, investigators propose to study the effects of motor tFUS on motor-evoked potentials (MEPs) and GABA concentration. The proposed research is critical for understanding tFUS and advancing its therapeutic potential for future clinical trials.

Interventions

This aim will test whether motor tFUS parameters thought to be excitatory (50% duty cycle) vs. inhibitory (5% duty cycle) elicit their predicted effects on MEPs before and after each of three stimulation blocks, using 50 MEPs at each time point.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER
BRAINBox Solutions Inc
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Caregiver)

Masking description

Device stimulation will be blinded by the outcomes assessor to maintain the blinding of the participants and care provider

Intervention model description

Within-subject, each participant will receive one excitatory course of stimulation and one inhibitory course of stimulation of the motor cortex.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female * Age 18-55 * Endorse good health with no history of mental or physical illness or implanted metal * English as a primary language * Capacity to consent * Negative urine pregnancy test if a female of childbearing potential * Willingness to adhere to the tFUS and MRI study schedule

Exclusion criteria

* Any psychotropic medication is taken within 5 half-lives of procedure time * Any head trauma resulting in loss of consciousness * Personal or family history of neurological illness or injury * Alcohol or substance abuse or dependence (other than tobacco) in the past week * Diagnosis or current treatment (pharmacological or otherwise) of any psychiatric condition * Pregnancy * Personal or family history of seizures or epilepsy * Claustrophobia or inability to stay still in the MR scanner environment * Any metal in the body * Other contraindications to electrical or electromagnetic stimulation * Hair in dreadlocks, braids, or weave * Diagnosis of COVID-19 in the past 14 days * Inability to adhere to the treatment schedule.

Design outcomes

Primary

MeasureTime frameDescription
Motor Evoked Potential AmplitudeImmediate Post-StimulationHow has the focused ultrasound stimulation affected MEP amplitude

Countries

United States

Contacts

CONTACTLisa M McTeague, Ph.D.
mcteague@musc.edu8437928274
CONTACTKevin A Caulfield
caulfiel@musc.edu

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026